|CRDAMC Homepage | CRDAMC Library Phone #: (254) 288-8366 | CRDAMC Library Fax #: (254) 288-8368|
by Jill Shuman, MS, RD, ELS
Psoriasis is a chronic, inflammatory skin disease. Knees, elbows, scalp, trunk, and nails are the most commonly affected areas. There are several types of psoriasis:
The cause of psoriasis is unclear. Signals from a defect in the immune system may result in an overgrowth of skin cells. Because the cells grow faster than they can be shed, they pile up on the skin's surface. The excess skin cells are thought to cause the silvery white scales that are characteristic of plaque-type psoriasis.
Risk Factors TOP
Factors that may increase your risk include:
The red, thickened, and rough patches of psoriasis may occur anywhere, but are commonly found on the scalp, elbows, knees, palms, and soles. Other symptoms include:
The skin may also be sore, burning, or itchy depending on the type of psoriasis.
The rashes may come and go.
You will be asked about your symptoms and medical history. A physical exam will be done. It will include an exam of your skin and nails will be examined. There are no specific blood tests or diagnostic procedures for psoriasis. Sometimes a skin biopsy will be done to confirm the diagnosis.
Treatment is based on:
Many patients respond well to treatments applied directly to the skin. Topical treatments include:
Photo (Light) Therapy
If psoriasis covers more than 30% of the body, it is difficult to treat with topical medications alone. Daily, short, nonburning exposure to sunlight clears or improves psoriasis in many people. Sunlight is often included among initial treatments.
A more controlled form of artificial light treatment (UVB phototherapy) is often used in cases that are more widespread. Alternatively, psoriasis can be treated with ultraviolet A (UVA light) and psoralen. Psoralen is an oral or topical medication that makes the body more sensitive to light. This treatment is known as PUVA.
Phototherapy can be very effective in controlling psoriasis but it requires frequent treatments. It may cause side effects such as nausea, headache, and fatigue, burning, and itching. Both UVB and PUVA may increase the person's risk for squamous cell and, possibly, melanoma skin cancers.
Systemic Treatment TOP
For more severe types of psoriasis, doctors may prescribe a number of other powerful medications, which can be effective, but are associated with side effects that are more serious. These include:
Avoiding physical trauma to the skin, infections, and cold, dry temperatures may help reduce flare-ups in people with the condition. You may be advised to avoid certain foods if they appear to make your psoriasis worse.
American Academy of Dermatology
National Psoriasis Foundation
Canadian Dermatology Association
Psoriasis Society of Canada
de Prost Y. New topical immunological treatments for psoriasis. J Eur Acad Dermatol Venereol. 2006;20(suppl 2):80-82.
Psoriasis. American Academy of Dermatology website. Available at: https://www.aad.org/dermatology-a-to-z/diseases-and-treatments/m---p/psoriasis. Accessed February 16, 2016.
Moderate to severe psoriasis: biologic drugs. National Psoriasis Foundation website. Available at: https://www.psoriasis.org/about-psoriasis/treatments/biologics. Accessed February 16, 2016.
Moderate to severe psoriasis: systemic medications—methotrexate. National Psoriasis Foundation website. Available at: https://www.psoriasis.org/about-psoriasis/treatments/systemics/methotrexate. Accessed February 16, 2016.
Psoriasis. DynaMed Plus website. Available at: http://www.dynamed.com/topics/dmp~AN~T116742/Psoriasis. Updated September 5, 2016. Accessed September 14, 2016.
Varani J, Bhagavathula N, Ellis CN, Pershadsingh HA. Thiazolidinediones: potential as therapeutics for psoriasis and perhaps other hyperproliferative skin disease. Expert Opin Investig Drugs. 2006;15:1453-1468.
10/2/2009 DynaMed's Systematic Literature Surveillance
...(Click grey area to select URL)
FDA approves new drug to treat psoriasis. US Food and Drug Administration website. Available at: http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm183851.htm. Published September 25, 2009. Accessed January 22, 2015.
Last reviewed March 2017 by EBSCO Medical Review Board Michael Woods, MD, FAAP
Last Updated: 3/17/2014
EBSCO Information Services is fully accredited by URAC. URAC is an independent, nonprofit health care accrediting organization dedicated to promoting health care quality through accreditation, certification and commendation.
This content is reviewed regularly and is updated when new and relevant evidence is made available. This information is neither intended nor implied to be a substitute for professional medical advice. Always seek the advice of your physician or other qualified health provider prior to starting any new treatment or with questions regarding a medical condition.
To send comments or feedback to our Editorial Team regarding the content please email us at firstname.lastname@example.org. Our Health Library Support team will respond to your email request within 2 business days.